Nicola Dagg

Kirkland & Ellis International LLP

Nicola is an IP litigation partner in Kirkland & Ellis’ London office. Nicola’s practice spans four areas: patent litigation; standard essential patent (SEP) and FRAND disputes; co-ordinating global IP enforcement/defence cases; and strategic life sciences patent and product lifecycle advice. She acts in market leading SEP essentiality, validity and global FRAND adjudication litigation in the tech sector. Nicola has extensive experience in pharmaceutical and biologics patent litigation including blockbuster small molecule litigation against generic companies, biologics and biosimilar litigation, antibodies, immunotherapies, genetics, vaccines, diagnostics and gene therapies. Having served as UK and European/global co-ordinating counsel for numerous strategic IP litigation cases and drawing on more than 24 years of legal, IP, life sciences and tech experience, she helps clients solve their most pressing global challenges.
Chambers Global, Chambers UK, Legal 500, and IAM Patent 1000 rank Nicola as a leading IP partner.